Waive Medical, the first startup from Sudbury to graduate from Google for Startups, is gearing up for a US expansion following successful clinic partnerships and promising revenue growth.
- Waive Medical uses AI to automate clinic administrative tasks
- Generated $2.2 million in revenue with steady clinic onboarding
- Preparing US launch with leadership relocating to San Francisco
What happened
Waive Medical recently became the first and only startup from Sudbury, Ontario, to graduate from the Google for Startups accelerator. The company showcased strong performance during the accelerator’s demo day in Toronto, attributing operational success to its AI-based platform that automates administrative work for clinics. This automation has saved client clinics hundreds of hours of labor each month.
Following this milestone, Waive Medical is preparing to raise a Series A funding round to support its planned expansion into the US. The company has already initiated its US market entry with a successful trial client and is establishing a presence by relocating co-founder Tabassum Pasha to San Francisco to spearhead local growth efforts.
Why it matters
Waive Medical’s growth highlights the potential for healthtech startups emerging from less traditional tech hubs like Sudbury. The city’s supportive investment environment, exemplified by NORCAT’s early backing, and regional healthcare resources such as Health Sciences North, present unique advantages for innovation in medical administration technology.
Streamlining administrative workloads in clinics using AI addresses a critical bottleneck in healthcare delivery by reducing time, costs, and wait times. As the company builds traction in Canada with established networks such as Well Health and Loblaw, its US expansion could significantly influence health service efficiency on a larger scale.
What to watch next
Key developments to follow include Waive Medical’s progress in securing its Series A funding and how effectively it scales its AI platform within the competitive US healthcare market. Monitoring adoption rates among clinics and partnerships with major healthcare providers will be critical indicators of growth potential.
Additionally, the dual leadership approach—with one co-founder focusing on Canadian operations while the other drives US market penetration—will be important to watch. The results of this bifurcated strategy could provide valuable insights into managing international expansion for Canadian healthtech startups.